The national study of over 60,000, researchers concluded that asthma symptoms worsened in the six months following a COVID-19 infection.
Common theme of hope resonates at inaugural CHOC/UCI Rare Disease Symposium and Family Conference
At the inaugural CHOC/UCI Rare Disease Conference, providers discussed plans for extended research, collaboration and treatment strategies.
Bounce house injuries continue to jump
A CHOC-led study on the frequency of bounce house injuries reveals the safety concerns and the need for prevention tactics.
CHOC serves as leading voice for innovative pediatric healthcare practices
In a webinar with U.S. News & World Report, Dr. Anthony Chang discusses how the COVID-19 pandemic propelled medical innovation at CHOC.
Medical device research leads to improved neonatal care
A partnership between CHOC and Masimo has developed technology to noninvasively monitor blood oxygen and hemoglobin levels in newborns.
Innovative protocol studies treatment for rare pediatric PTCL and NK/T-Cell lymphoma
CHOC helps develop innovative treatment protocols for PTCL and NK/T-cell lymphoma, which are now available for patients.
